Skip to Content

A U of M startup was named among the companies with the highest fundraising rounds this year.

Miromatrix Medical, a biotech startup using research from the University of Minnesota to turn pig organs into transplantable human organs, closed its Series B round at $15.7 million. Miromatrix surpassed its original goal of $10 million for this round, and welcomed its first large strategic investor – a “multibillion-dollar healthcare company” that Miromatrix did not name in its release.

Read the full story in Minne Inno.